Bausch + Lomb is an eye-health company that makes contact lenses, lens-care products, ophthalmic pharmaceuticals, and surgical devices for vision care.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Daniel Loeb / Third Point | 39 | New buy | 85,000 | $1,407,600 | 0.0% |
| Paul Tudor Jones / Tudor | 63 | Added +41% | 532,030 | $8,810,417 | 0.0% |
| Carl Icahn | 10 | Holds (flat) | 3,500,000 | $57,960,000 | 0.7% |
| Larry Robbins / Glenview | 58 | Holds (flat) | 1,918,148 | $31,764,531 | 0.6% |
| Howard Marks / Oaktree | 71 | Trimmed -66% | 3,441,042 | $56,983,655 | 0.8% |
| Steve Cohen / Point72 | 76 | Trimmed -38% | 175,819 | $2,911,567 | 0.0% |
| Filed | Insider | Role | Shares | Value | |
|---|---|---|---|---|---|
| 2026-03-10 | Bailey A Robert D (cluster of 3) | officer | 14,600 | $250,390 | Form 4 |
| 2026-03-10 | SAUNDERS BRENT L (cluster of 3) | director+officer | 14,700 | $251,958 | Form 4 |
| 2026-02-24 | COLLIS STEVEN H (cluster of 3) | director | 15,000 | $267,150 | Form 4 |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-09-24.